guanfacine has been researched along with Altitude Hypoxia in 2 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guanfacine treatment significantly increased the expression of BDNF in layer II of the medial PFC during normoxia and HH." | 1.43 | Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxia. ( Kauser, H; Panjwani, U; Sahu, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kauser, H | 2 |
| Sahu, S | 2 |
| Kumar, S | 1 |
| Panjwani, U | 2 |
2 other studies available for guanfacine and Altitude Hypoxia
| Article | Year |
|---|---|
Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline.
Topics: Adrenergic alpha-2 Receptor Agonists; Altitude Sickness; Animals; Cognition Disorders; Dendrites; Gu | 2013 |
Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxia.
Topics: Altitude Sickness; Analysis of Variance; Animals; bcl-2-Associated X Protein; Brain-Derived Neurotro | 2016 |